| 产品编号 | D50502 |
| 英文名称 | Lopinavir |
| 中文名称 | 洛匹那韦 |
| 别 名 | (aS)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-α-(1-methylethyl)-2-oxo-1(2H)-Pyrimidineacetamide; Koletra; (2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenyl-hexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide; Lopinavir(ABT-378); Lopinavir(350mg); (αS)-N-[(1S,3S,4S)-4-[[2Chemicalbook-(2,6-DiMethylphenoxy)acetyl]aMino]-3-hydroxy-5-phenyl-1-(phenylMethyl)pentyl]tetrahydro-α-(1-Methylethyl)-2-oxo-1(2H)-pyriMidineacetaMide; (2S)-N-[(2S,4S,5S)-5-[2-(2,6-diMethylphenoxy)acetaMido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-Methyl-2-(2-oxo-1,3-diazinan-1-yl)butanaMide; (S)-N-((2R,4S,5S)-5-(2-(2,6-Dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenyl-hexn-2-yl)-3-methyl; CS-546; 匹洛那韦; 洛比那韦; 洛匹那韦LOPINAVIR; 罗平拉韦; 洛匹那韦(标准品); (2S)-N-[(2R,4S,5S)-5-[[2-(Chemicalbook2,6-二甲基苯氧基)乙酰]氨基]-4-羟基-1,6-二苯基-己-2-基]-3-甲基-2-(2-氧代-1,3-二氮杂环己-1-基)丁酰胺; 洛匹那韦; |
| 克 隆 号 | |
| CAS | 192725-17-0 |
| 理论分子量 | kDa |
| 检测分子量 | |
| 保存条件 | Store at -20℃. 惰性气氛下;. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 |
CAS号：192725-17-0 分子式：C37H48N4O5 分子量：628.8 MDL：MFCD22373646 级别：AR 纯度：99% 外观/性状：白色粉末。 溶解性：溶于DMSO, 敏感性：吸湿性 作用靶点：HIV; HIV Protease; SARS-CoV; 作用通路：Anti-infection; Metabolic Enzyme/Protease; 描述：洛匹那韦（Lopinavir）是一种有效的 HIV protease（HIV蛋白酶）抑制剂，Ki为1.3pM。 |
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
